retatrutide triple agonist phase 2 obesity trial Severe Shows 30% Weight Loss π¨ BREAKING: Retatrutide Shows βBariatric-Levelβ
Description
For tirzepatide, 4 days
"Not only can they decrease the user's BMI but they also carry metabolic and cardiovascular benefits as well
by maintaining the functioning of blood vessels and reducing blood pressure and heart rate as observed in animal models and supported by human data
Contrary to the decrease in HbA1c values that attained a plateau after 24 weeks, weight reduction with retatrutide continued to progress to the end of follow-up at 36 weeks [4]
Drtsel yeme ataklarnn azalmas, gece yeme alkanlklarnn kontrol altna alnmas ve porsiyon farkndalnn artmas bu etkiler arasndadr
